Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units
摘要:
Extensive molecular modelling studies, including conformational analysis and the comparison of molecular electrostatic potential distributions, were used to evaluate structural parameters of new antagonists containing acyclic replacements of the N = C-N imidazole region. The synthesis and the biological screening of a series of acyl biphenyltetrazole derivatives were planned and realized to gain an insight into the structure-activity relationships of this unusual class of Angiotensin II antagonists. (C) 1998 Elsevier Science Ltd. All rights reserved.
Design and synthesis of nonpeptide angiotensin II receptor antagonists featuring acyclic imidazole-mimicking structural units
摘要:
Extensive molecular modelling studies, including conformational analysis and the comparison of molecular electrostatic potential distributions, were used to evaluate structural parameters of new antagonists containing acyclic replacements of the N = C-N imidazole region. The synthesis and the biological screening of a series of acyl biphenyltetrazole derivatives were planned and realized to gain an insight into the structure-activity relationships of this unusual class of Angiotensin II antagonists. (C) 1998 Elsevier Science Ltd. All rights reserved.
SUND E. H.; CASHON R. E.; TAYLOR R. L., TEX. J. SCI., 1980, 32, NO 1, 93-94
作者:SUND E. H.、 CASHON R. E.、 TAYLOR R. L.
DOI:——
日期:——
[EN] NOVEL INHIBITORS OF GLUTAMINASE<br/>[FR] NOUVEAUX INHIBITEURS DE GLUTAMINASE
申请人:RHIZEN PHARMACEUTICALS SA
公开号:WO2015101958A2
公开(公告)日:2015-07-09
The present disclosure provides compounds of formula (I) to (III) as glutaminase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders involving glutamine.